These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10334196)

  • 1. Combined mismatch and nucleotide excision repair defects in a human cell line: mismatch repair processes methylation but not UV- or ionizing radiation-induced DNA damage.
    O'Driscoll M; Martinelli S; Ciotta C; Karran P
    Carcinogenesis; 1999 May; 20(5):799-804. PubMed ID: 10334196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPC lymphoblastoid cells defective in the hMutSalpha DNA mismatch repair complex exhibit normal sensitivity to UVC radiation and normal transcription-coupled excision repair of DNA cyclobutane pyrimidine dimers.
    Kobayashi K; O'Driscoll M; Macpherson P; Mullenders L; Vreeswijk M; Karran P
    DNA Repair (Amst); 2004 Jun; 3(6):649-57. PubMed ID: 15135732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
    Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cells bearing homozygous mutations in the DNA mismatch repair genes hMLH1 or hMSH2 are fully proficient in transcription-coupled nucleotide excision repair.
    Rochette PJ; Bastien N; McKay BC; Therrien JP; Drobetsky EA; Drouin R
    Oncogene; 2002 Aug; 21(37):5743-52. PubMed ID: 12173044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage.
    Aquilina G; Crescenzi M; Bignami M
    Carcinogenesis; 1999 Dec; 20(12):2317-26. PubMed ID: 10590226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of an involvement of the human mismatch repair genes hMLH1 and hMSH2 in nucleotide excision repair is dependent on UVC fluence to cells.
    Lee DF; Drouin R; Pitsikas P; Rainbow AJ
    Cancer Res; 2004 Jun; 64(11):3865-70. PubMed ID: 15172995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair.
    Leadon SA; Avrutskaya AV
    Cancer Res; 1997 Sep; 57(17):3784-91. PubMed ID: 9288788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.
    Levati L; Marra G; Lettieri T; D'Atri S; Vernole P; Tentori L; Lacal PM; Pagani E; Bonmassar E; Jiricny J; Graziani G
    Genes Chromosomes Cancer; 1998 Oct; 23(2):159-66. PubMed ID: 9739019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
    Branch P; Hampson R; Karran P
    Cancer Res; 1995 Jun; 55(11):2304-9. PubMed ID: 7757980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch repair and DNA damage signalling.
    Stojic L; Brun R; Jiricny J
    DNA Repair (Amst); 2004; 3(8-9):1091-101. PubMed ID: 15279797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents.
    Armstrong MJ; Galloway SM
    Mutat Res; 1997 Feb; 373(2):167-78. PubMed ID: 9042397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2.
    Pitsikas P; Lee D; Rainbow AJ
    Mutagenesis; 2007 May; 22(3):235-43. PubMed ID: 17351251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
    Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
    Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased UV sensitivity, mismatch repair activity and abnormal cell cycle checkpoints in skin cancer cell lines derived from UVB-irradiated XPA-deficient mice.
    Ichikawa M; Nakane H; Marra G; Corti C; Jiricny J; Fitch M; Ford JM; Ikejima M; Shimada T; Yoshino M; Takeuchi S; Nakatsu Y; Tanaka K
    Mutat Res; 2000 May; 459(4):285-98. PubMed ID: 10844242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
    Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
    Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
    Cortellino S; Turner D; Masciullo V; Schepis F; Albino D; Daniel R; Skalka AM; Meropol NJ; Alberti C; Larue L; Bellacosa A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15071-6. PubMed ID: 14614141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.